The Bergen 4-day treatment for panic disorder: implementation in a rural clinical setting

Eide, Thorstein Olsen; Hjelle, Kay Morten; Sætre, Ida Ueland; Solem, Stian; Olsen, Thorbjørn; Sköld, Rolf Olof; Kvale, Gerd; Hansen, Bjarne; Hagen, Kristen

doi:10.1186/s12888-023-04812-x

Cited by 3 publications

(1 citation statement)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The expectation maximization (EM) method was performed in SPSS version 29 to impute missing data. This method was utilized because the dataset had less than 25% missing data, and the missing data were found to be missing at random based on Little's MCAR test ( x 2 [ 27 ] = 29.47, p = 0.34) and Kolmogorov–Smirnov test indicated that the data were normally distributed. When these conditions are met, EM is a reliable approach for imputing missing data [ 39 ].…”

Section: Methodsmentioning

confidence: 99%

The Bergen 4-day treatment for social anxiety disorder: a pilot study

Hansen,

Eide,

Reiråskag

et al. 2024

BMC Psychiatry

Self Cite

View full text Add to dashboard Cite

Background Few studies have examined the use of concentrated and intensified cognitive behaviour therapy for treating social anxiety disorder (SAD). The aim of this study was to examine the feasibility of the Bergen 4-Day Treatment (B4DT) for treating SAD. Methods This study adopted an open trial design without a control group. Thirty consecutively referred patients who were diagnosed with SAD were treated and assessed at pre-treatment, at post-treatment, and at the 3-month follow-up. The Liebowitz Social Anxiety Scale was used to assess symptoms of SAD; the Generalized Anxiety Disorder-7 scale was used to assess anxiety symptoms; and the Patient Health Questionnaire-9 was used to assess symptoms of anxiety and depression. The Client Satisfaction Questionnaire-8 was administered posttreatment. Results Overall, patients reported a high level of satisfaction with the B4DT. Large effect sizes were observed for symptoms of SAD (d = 1.94–2.66) and for the secondary outcomes, i.e., generalized anxiety (d = 0.86–0.99) and depression (d = 0.62–0.83). The remission rate was 55.2% at follow-up, while the treatment response rate was 89.7%. Conclusions The B4DT is a promising treatment approach for patients with SAD. In the future, controlled trials should be performed to compare the efficacy of this treatment approach with standard outpatient treatment. Practical consequences, policy implications, and suggestions for future research are discussed herein.

show abstract

Section: Methodsmentioning

confidence: 99%

The Bergen 4-day treatment for social anxiety disorder: a pilot study

Hansen,

Eide,

Reiråskag

et al. 2024

BMC Psychiatry

Self Cite

View full text Add to dashboard Cite

show abstract

Long-term follow-up of the Bergen 4-day treatment for panic disorder during the COVID-19 pandemic

Hjelle,

Eide,

Thorsen

et al. 2024

Cogent Psychology

View full text Add to dashboard Cite

The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities

et al. 2023

Self Cite

View full text Add to dashboard Cite

Background The Bergen 4-day treatment (B4DT) is a concentrated exposure-based therapy that has been shown to be effective in the treatment of anxiety disorders. The current study sought to examine the effectiveness of B4DT for panic disorder (PD), when delivered with a combination of face-to-face sessions and videoconferencing. Methods Treatment was delivered to 50 patients from April 2020 to May 2021. Because of regulations during the pandemic, a significant portion of the treatment was conducted via videoconference. The primary outcome measure was the clinician-rated Panic Disorder Severity Scale (PDSS), and secondary measures included patient-rated symptoms of panic disorder, agoraphobia, generalized anxiety, depression, and treatment satisfaction. Changes in symptom levels over time were estimated using multilevel models. Results Patients showed a significant reduction in clinician-rated symptoms of panic disorder (Measured by PDSS) from before treatment to post treatment (d = 2.18) and 3-month follow-up (d = 2.01). At three months follow-up 62% of patients were classified as in remission, while 70% reported a clinically significant response. We also found a reduction in symptoms of depression and generalized anxiety, and the patients reported high satisfaction with the treatment. Conclusion The current study suggests that B4DT delivered in a combination of videoconference and face-to-face meetings may be a useful treatment approach. As the study is uncontrolled, future studies should also include more strictly designed investigations.

show abstract

The Bergen 4-day treatment for panic disorder: implementation in a rural clinical setting

Cited by 3 publications

References 38 publications

The Bergen 4-day treatment for social anxiety disorder: a pilot study

The Bergen 4-day treatment for social anxiety disorder: a pilot study

Long-term follow-up of the Bergen 4-day treatment for panic disorder during the COVID-19 pandemic

The Bergen 4-day treatment for panic disorder: adapting to COVID-19 restrictions with a hybrid approach of face-to-face and videoconference modalities

Contact Info

Product

Resources

About